Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Population Pharmacokinetics (PopPK) in
Population Pharmacokinetics (PopPK) in Biosimilar Studies: Purpose, Challenges, Solutions, and..
Read More ...Ultrasensitive Solutions for HCP
Now Streaming On-Demand Our platform represents a significant advancement in..
Read More ...Register Now
Global Bioanalysis Workshop in Bangladesh: The Global Bioanalysis Workshop on..
Read More ...Immunogenicity
Immunogenicity Solutions In-silico Analysis T-cell epitope mapping system B-cell epitope..
Read More ...